Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Journey Medical Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 36 | 37 | +1 |
| Shares | 2.16M | 3.79M | +1.63M (+75.6%) |
| Value | $12.2M | $14.8M | +$2.63M (+21.6%) |
New holders (7)
Institutions that held Journey Medical Corp at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 1,725,569 | $6.75M | 0.45% |
| Citadel Advisors LLC | 44,568 | $174.3K | 0.00% |
| UBS Group AG | 22,363 | $87.4K | 0.00% |
| Dimensional Fund Advisors LP | 20,455 | $80.0K | 0.00% |
| Susquehanna International Group, LLP | 18,722 | $73.2K | 0.00% |
| Kestra Advisory Services, LLC | 15,000 | $58.6K | 0.00% |
| Morgan Stanley | 9,700 | $37.9K | 0.00% |
Sold out (6)
Institutions that held Journey Medical Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Rosalind Advisors, Inc. | 105,917 | $598.4K |
| Walleye Capital LLC | 23,098 | $130.5K |
| Perkins Capital Management Inc | 22,000 | $124.3K |
| Wealthcare Capital Management LLC | 10,000 | $56.5K |
| Federated Hermes, Inc. | 853 | $4.82K |
| JPMorgan Chase & Co | 469 | $2.65K |